GRAIL alternatives and competitors
The closest alternatives to GRAIL are Freenome, Guardant Health, bioAffinity Technologies and Helix.
Multi cancer early detection company (NASDAQ: GRAL). The Galleri test uses targeted methylation sequencing of cell free DNA from a blood draw, with machine learning classifiers that detect a cancer signal and predict its origin, across more than 50 cancer types.
10 alternatives to GRAIL
What each product does, with its price as the vendor publishes it.
-
F
Cancer screening company (NASDAQ: FRNM) whose blood tests run on a multiomics platform that reads cell free DNA methylation at single base resolution, alongside protein and autoantibody signals, with machine learning classifiers producing the result.
Price: No published price
-
G
Guardant Health is a publicly traded precision oncology company (Nasdaq: GH), founded in 2012 and based in Palo Alto, California, that runs blood and tissue cancer tests in its own laboratories.
-
B
bioAffinity Technologies (NASDAQ: BIAF) develops noninvasive tests for lung disease, led by CyPath Lung, a laboratory developed test that pulmonologists and other physicians order for high risk patients with indeterminate pulmonary nodules.
Price: No published price
-
H
Genomics company in San Mateo, California, sequencing with its proprietary Exome+ assay in a CLIA certified, CAP accredited laboratory.
Price: No published price
-
B
Precision oncology company in Waltham, Massachusetts, combining sequencing in its own CAP accredited, CLIA certified laboratory with models of tumor and immune biology.
Price: No published price
-
C
Caris Life Sciences (NASDAQ: CAI) is a precision oncology company in Irving, Texas. It profiles tumors in its own laboratories by whole exome and whole transcriptome sequencing and layers AI signatures on the results.
Price: No published price
-
V
Veracyte sells genomic tests that pair a laboratory expression assay with a learned classifier, used by urologists, oncologists and endocrinologists to decide how intensively to treat a cancer or whether a thyroid nodule needs surgery.
Price: No published price
-
G
Genomics trades as Genomics and is registered in England as Genomics Ltd, formerly Genomics plc. Its US arm, Genomics Inc., is wholly owned by Genomics Ltd.
Price: No published price
-
M
MyOme is a genomics company in Menlo Park, California, with a CLIA certified and CAP accredited laboratory, that sells whole genome screening built around integrated risk scores.
Price: No published price
-
G
Rare disease genomic diagnosis company (NASDAQ: WGS) in Gaithersburg, Maryland, running exome and genome sequencing in its own accredited laboratory and interpreting it with automation, machine learning and clinical scientists over GeneDx Infinity, its dataset of prior cases.
Price: No published price
GRAIL alternatives, answered
What are the best alternatives to GRAIL?
The closest alternatives to GRAIL are Freenome, Guardant Health, bioAffinity Technologies, Helix and BostonGene. Guardant Health is a publicly traded precision oncology company (Nasdaq: GH), founded in 2012 and based in Palo Alto, California, that runs blood and tissue cancer tests in its own laboratories. bioAffinity Technologies (NASDAQ: BIAF) develops noninvasive tests for lung disease, led by CyPath Lung, a laboratory developed test that pulmonologists and other physicians order for high risk patients with indeterminate pulmonary nodules.
Who are GRAIL's competitors?
GRAIL's competitors in the Diagnostics & Genomics category include Freenome, Guardant Health, bioAffinity Technologies, Helix, BostonGene and Caris Life Sciences.